Fig. 1 Schematic of energy metabolism dysfunction promoting carcinogenic risks and cancer development.
Impaired adipose tissue angiogenesis could potentially limit adipogenesis and thereby contribute to metabolic dysfunction by promoting ectopic lipid accumulation [ 6].
Energy metabolic dysfunction can promote the establishment of a hypoxic microenvironment, particularly through abnormal mitochondrial aerobic respiration and increased rate of glycolysis.
Edwards MR, Sultan P, del Arroyo AG, Whittle J, Karmali SN, Moonesinghe SR, et al. Metabolic dysfunction in lymphocytes promotes postoperative morbidity.
These results demonstrate that the loss of MTMR14 promoted metabolic dysfunction and inflammation in fat, muscle and liver, particularly in aged mice.
Both high fat diet and eRAPA impaired glucose and insulin tolerance at each time points, but we found no significant interaction effect suggesting that eRAPA promoted metabolic dysfunction equally in both low fat and high fat diets.
The study particular highlights the need for new research on PAR2 in metabolism and metabolic dysfunction.
We propose that owing to the important role of energy metabolism dysfunction in promoting cancer risks, energy metabolic dysfunction as a carcinogenic factor cannot be ignored.
Thus, the converse approach, i.e. enhancing adipose tissue angiogenesis, preferably in the subcutaneous depot, should promote fat storage in the appropriate tissue and subsequently protect against metabolic dysfunction.
We postulate that the metabolic dysfunction associated with hyperglycemia and dyslipidemia in concert with reduced neurotrophic support promotes deterioration and reduced regeneration of the distal axon.
